AlphaYouRG
Schedule 13G filing
Redmile Group, LLC disclosed a 8.7% stake in Electra Therapeutics, Inc. (ETRA)
Redmile Group, LLC reported owning 8.7% of Electra Therapeutics, Inc. (ETRA) (5,462,881 shares) in a Schedule 13G filed Sep 29, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Sep 29, 2026
- Source
- Schedule 13G
More ETRA insider and Congress trades
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.